Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery

Obesity Surgery

Volumn 23, Issue 7, 2013, Pages 867-873

  Aarts, E O ^a   Janssen, J ^a   Janssen, I M C ^a   Berends, F J ^a   Telting, D ^a   De Boer, H ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

C peptide; Obesity; Roux en Y gastric bypass; Type 2 diabetes mellitus

Indexed keywords

GLICLAZIDE; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TOLBUTAMIDE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY WEIGHT; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84878912375     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0872-8     Document Type: Article

References (19)

1. Bult MJF et al. Surgical treatment of obesity. European Journal of Endocrinology. 2008;158:135-45.
2. Levy P, Fried M, et al. The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg. 2007;17:1248-56.
3. Buchwald H, Estok R, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256 e5.
4. Vetter ML, Cardillo S et al. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus, Ann Intern Med 2009; 20;150(2):94-103.
5. Wahren J, Ekberg K, Jornvall H. C-peptide is a bioactive peptide. Diabetologica. 2007;50:5003-9.
6. Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Cli Sci. 2009;116:565-74.
7. Luppi P, Cifarelli V, Wahren J. C-peptide and long term complications of diabetes. Pediatr Diabetes. 2011;12:276-92.
8. Pories WJ et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-50.
9. Colquitt JL, Picot J, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:CD003641.
10. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hama G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-84. discussion 84-5.
11. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751-6. discussion 757-8.
12. Brandenburg D. History and diagnostic significance of C-peptide. Exp Diabetes Res 2008: 576862.
13. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of Diabetes remission after Gastrointestinal Surgery. Endocrinology. 2009;150:2518-25.
14. Gastrointestinal Surgery for Severe Obesity National Institutes of Health: Consensus Development Conference Statement, March 25-27, 1991.
15. Sturm R. Increases in clinically severe obesity in the United States. Arch intern med. 2003;163:2146-8.
16. Bose M et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence. Obes Surg. 2009;19:217-29.
17. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med. 2004;351:2683-93.
18. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.
19. Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009;32:580-4.